TY  - JOUR

T1  - Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.

JO  - Clin Oncol (R Coll Radiol)

PY  - 2008/09/01

AU  - Zekri JM

AU  - El-Helw LM

AU  - Purohit OP

AU  - Hatton MQ

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/j.clon.2008.03.016

VL  - 20

IS  - 7

SP  - 513

EP  - 516

Y2  - 2025/10/10

ER  -